Article Information
History
- July 29, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Patricia J. Rodriguez, PhD, MPH1,
- Vincent Zhang, BA2,
- Samuel Gratzl, PhD1,
- Duy Do, PhD1,
- Brianna Goodwin Cartwright, MS1,
- Charlotte Baker, DrPH, MPH, CPH1,
- Ty J. Gluckman, MD, MHA3,
- Nicholas Stucky, MD, PhD1 and
- Ezekiel J. Emanuel, MD, PhD2,*
- 1Truveta, Inc, Bellevue, WA
- 2Healthcare Transformation Institute, Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
- 3Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Providence Health System, Portland, OR
- ↵*Corresponding Author: Ezekiel J. Emanuel, MD, PhD 423 Guardian Drive, Philadelphia, PA 19104 zemanuel{at}upenn.edu, (202) 498-6402
Posted July 29, 2024.
Discontinuation and Reinitiation of GLP-1 Receptor Agonists Among US Adults with Overweight or Obesity
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
6
Blogs/Media
Author Videos